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Objectives. This study analyzes our experience with transplan- 
tation of small donor hearts in a subgroup of moribund patients 
who could not be bridged to transplantation with mechanical 
assist devices. 
Background. The major problem facing transplant programs in 
the United States is the lack of donor heart availability. One 
method of expanding the donor pool may be to liberalize the 
criteria for an acceptable donor heart. 
Methods. We analyzed the growth and adaptation of 14 under- 
sized and 14 conventionally sized donor hearts over a period of 10 
weeks after heart ransplantation. The left ventricular systolic and 
diastolic diameters, septal and posterior wall thicknesses, left 
ventricular mass calculated by the Penn convention and left 
ventricnlar ejection fraction were obtained by M-mode and two- 
dimensional echocardiography and documented bya single reader 
in blinded manner. Echocardiographic measurements were ob- 
tained before implantation and at 5 and 10 weeks after orthotopic 
heart ransplantation. 
Results. The mean (+-SD) donor/recipient weight ratios were 
0.53 +- 0.06 for undersized hearts and 0.98 -+ 0.05 for normal- 
sized hearts. All 28 patients received similar immunosuppressive 
regimens, including intravenous steroids, cyeiosporine and aza- 
thioprine. The length of hospital stay after transplantation didnot 
vary significantly between the two groups. All the patients had at 
least one rejection episode during the 10-week study period. There 
was a tendency toward higher pulmonary pressures in undersized 
hearts, which was not statistically significant. Heart rate was 
significantly higher for undersized hearts, due in part to the use of 
theophylline or terbutaline tomaintain tachycardia. There was a 
significant increase in left ventricular systolic and diastolic di- 
mensions in undersized hearts compared with conventionally 
sized hearts. Undersized hearts increased in left ventricular mass 
over the 10-week period, whereas the conventionally sized donor 
hearts did not change between 5 and 10 weeks. 
Conclusions. In undersized hearts the increase in left ventric- 
ular mass and internal dimensions, with preservation of the 
posterior/septal wall thickness ratio, suggests hat the left ventri- 
cle adapts to the larger ecipient circulation early after transplan- 
tation. Despite denervation and a mismatched load, undersized 
transplanted hearts adapt appropriately to their new hemody- 
namic milieu. 
(J Am Coll Cardiol 1995;26:737-42) 
The growing prevalence of congestive heart failure has in- 
creased the demand for heart transplantation. Approximately 
2.5 to 3 million Americans carry the diagnosis of heart failure, 
which represents -1% of the population. Heart failure is the 
only cardiovascular disorder that is increasing in prevalence in
the United States (1). Every year -14,000 people become 
eligible for heart transplantation, but despite aggressive du- 
cational programs, the number of donors (and therefore 
transplants) has plateaued over the past 3 years according to 
the United Network of Organ Sharing (UNOS) registry. As the 
number of people awaiting heart ransplantation increases, the 
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major problem facing transplant programs in the United States 
is the lack of donor heart availability. Reports uggest (2) that 
upward of 30% to 50% of listed patients will expire awaiting 
donor hearts. 
Alternatives to allotransplantation, such as the develop- 
ment of extended-use mechanical assist devices, and xeno- 
transplantation are still in the very early stages of investigation 
and cannot replace heart transplantation. Thus, one method 
available to alleviate this organ shortage isthe expansion of the 
donor pool. 
The criteria for an acceptable donor heart have evolved 
since the inception of heart ransplantation. Many centers are 
reporting success with liberalization of weight range, selective 
use of "older" (>55 years old) hearts with coronary artery 
disease or left ventricular dysfunction, and longer ischemic 
times (3-6). Current reports (7) suggest that a donor/recipient 
weight ratio of 0.71 is an acceptable weight range for trans- 
plantation, as is a donor/recipient weight ratio of 0.67 for 
extremely ill patients. Previous tudies (8) involving undersized 
donor hearts have shown that the 1-year survival data are 
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similar to those of larger size-matched hearts. Hemodynamic 
variables and oxygen consumption exercise capacity are also 
not significantly different for either group (9). These findings 
have made undersizing an attractive consideration for expand- 
ing the donor pool. Also, when undersized onor hearts are 
utilized, the waiting time on the donor registry transplant list 
has been significantly shorter (10). 
The present study attempts to analyze and report our 
experience with transplantation of small donor hearts, many of 
which were below a donor/recipient weight ratio of 0.50, in a 
subgroup of moribund patients who could not be bridged to 
transplantation with mechanical ventricular assist devices. 
Methods  
Study patients. Over a 10-month period (July 1992 to May 
1993), 59 adult heart transplantations were performed at 
Temple University Hospital. During this period, we prospec- 
tively studied 14 patients whose condition deteriorated rapidly 
while awaiting heart ransplantation. Of these 14 patients, 13 
were in cardiogenic shock, and I had Candida fungemia while 
his circulation was being maintained with a Thoratec ventric- 
ular assist device. The first 13 patients were not eligible for 
ventricular assist devices for various reasons, including aortic 
insufficiency, respiratory failure and previous thoracic surgery 
using a sternotomy approach. The patients were hemodynam- 
ically supported with intraaortic balloon counterpulsation. 
Because of rapidly deteriorating clinical courses, the lower 
limit of donor/recipient weight ratio was extended to 0.40 (60% 
below recipient weight). Orthotopic heart ransplantation was 
undertaken when a suitable donor was available. 
Weight information. Donor weight was obtained by the 
organ procurement organization at the time of donor evalua- 
tion. The weight of the recipient at the time of upgrading to 
UNOS status 1 was used along with the donor weight to 
calculate the donor/recipient weight ratio. 
Transplantation procedure. The undersized onor hearts 
were harvested and implanted using the protocol described by 
Jeevanandam et al. (l 1). The donor hearts were harvested 
after administration f an intravenous bolus of 0.4 #g/kg of 
triiodothyronine (T3, Triostat, SmithKline Beecham). After 
cardiopulmonary b pass was initiated for the recipient, a 
0.12-ng/kg per rain continuous infusion of prostaglandin E~ 
(Prostin, Upjohn) was started. 
The immunosuppression protocols for both the undersized 
donor hearts and the control group were similar, with all 
patients receiving intravenous methylprednisolone followed by 
triple therapy with oral prednisone, azathioprine (2to 4 mg/kg 
per day) and cyclosporine A (titrated to maintain a whole- 
blood Abbott TDX level between 250 and 350 ~g/ml). Two of 
the patients receiving undersized donor hearts required induc- 
tion therapy with antithymocyte globulin (ATGAM, Upjohn) 
for 5 days, instead of early postoperative cyclosporine A, 
because of anuria. In these two patients, cyclosporine A was 
initiated on postoperative day 3, and the antithymocyte glob- 
ulin was discontinued by day 5. 
Early postoperative critical care management. The imme- 
diate postoperative goals for the undersized hearts were to 
optimize cardiac output by minimizing pulmonary and systemic 
vascular esistances and maximizing preload (pulmonary cap- 
illary wedge pressure 18 to 21 mm Hg). To maintain cardiac 
output, heart rate was increased by external pacing using the 
epicardial pacing wires. Pulmonary vascular resistance was 
reduced by intravenous prostaglandin Ej and nitrate infusions, 
hyperventilation, sedation and paralysis. Afterload was re- 
duced by intravenous prostaglandin El, intraaortic balloon 
counterpulsation (which was maintained for 4 to 6 days in four 
patients after transplantation) and isoproterenol. As the he- 
modynamic and pulmonary function improved, the intraaortic 
balloon counterpulsation, pressors, mechanical ventilation and 
prostaglandin supports were slowly withdrawn over a mean 
(+-SD) of 6.5 _+ 4.3 days. In patients with undersized hearts, 
terbutaline or theophylline therapy was also started to main- 
tain a target heart rate. These medications were withdrawn 8 to 
12 weeks after transplantation when the echocardiograms 
revealed an increase in left ventricular mass and left ventricu- 
lar internal dimensions (12). 
Echocardiographic measurements. Echocardiographic 
measurements were obtained before implantation atthe donor 
hospital and then at the prescribed intervals of 5 and 10 weeks 
after transplantation. Echocardiographic studies were per- 
formed using a Hewlett-Packard Sonos 1000 ultrasound system 
with a 2.5/2.0-MHz and 3.5-MHz transducer (Hewlett-Packard 
Company). 
Two-dimensional echocardiography was used to determine 
left ventricular ejection fraction. M-mode echocardiography 
was used to assess cardiac variables. Images of the heart were 
obtained with the patient in the partial eft decubitus position 
and the transducer in the standard chest interspace. M-mode 
measurements of the left ventricular internal diameter at 
end-diastole (LVd) and at end-systole and posterior and septal 
wall thicknesses at end-diastole (PWT, SWT) were obtained 
for 28 donors before implantation and at 5- and 10-week 
intervals after transplantation. Left ventricular mass (LVM) 
was calculated using the geometric ube formula (13): 
LVM = 1.04[(LVd + PWT + SWT) ~ - (LVd) 3] × 0.8 + 0.6. 
Statistical analysis. Statistical differences between mean 
values for two groups were evaluated by the Student  test. 
Comparison of changes in left ventricular mass and left 
ventricular internal dimensions over time was performed with 
one-way analysis of variance. A p value <0.05 was considered 
significant. 
Results 
Undersized onor heart group. Recipients. The recipients 
of the undersized hearts (10 men, 4 women) had a mean 
(+SD) age of 51 + 12.2 years (range 34 to 64) and a mean 
weight of 71 ± 12.9 kg. Eleven recipients were in blood group 
O and 3 blood group A. Mean preoperative hemodynamic 
variables were as follows: mean systolic blood pressure 60.1 +_ 
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Table 1. Clinical Characteristics of 28 Study Patients 
Control Group 
(n = t~) 
Table 2. Hemodynamic Variables (mean _+ SD) 
Age (yr) 53 ± 13.9 51 ± 12.2 
Gender (M/F) 9/5 10/4 
Blood type 100, 3A, 1B II O, 3A 
Weight ratio 0.98 _+ 0.5 0.53 _+ 0.06 
PVR (Wood units) 2.5 + 0.6* 3.6 ± 0.6* 
Serum creatinine (mg/dl) 1.9 ± 0,8* 3.8 _+ 1.5' 
Undersized Cardiac Index 
Donor Heart PAP PCWP (liters/rain Heart Rate 
Group (mm Hg) (mm Hg) per m e) (beats/min) 
(n = 14) 5 wk 
Control hearts 26 ___ 5 14 ± 4 3.1 -+ 0.6 90 _+ 12' 
Undersized hearts 31 + 7 16 ± 6 2.8 _+ 0.7 122 ± 14" 
10 wk 
Control hearts 23 ~+ 6 12 ± 3 3.4 ± 0.5 84 +_ 14t 
Undersized hearts 29 ± 7 15 _+ 6 3.1 ± 0.8 116 ± 127 
*p < 0.05, undersized donor heart group versus control group. Data 
presented are mean value _+ SD or number of patients. F = female; M = male; 
PVR = pulmonary vascular resistance. 
12.7 mm Hg, mean pulmonary artery pressure 44 -+ 7.9 mm Hg, 
pulmonary capillary wedge pressure 31.5 ___ 7.6 mm Hg, pulmo- 
nary vascular esistance 3.6 -- 0.6 Wood units and cardiac index 
1.7 +_ 0.5 liters/rain per m 2. Mean serum creatinine level was 
3.8 _+ 1.5 mg/dl, and four patients were anuric. 
Donors. Donors (9 male, 5 female) had a mean age of 13.4 _+ 
5.3 years (range 8 to 33) and a mean weight of 35.6 + 7.1 kg. 
The average donor/recipient weight ratio was 0.53 _ 0.06 
(range 0.44 to 0.67). The average waiting period after expand- 
ing the weight range was 6.8 _+ 4.6 days. 
Control group. Recipients. The control group of 14 pa- 
tients (9 men, 5 women) had a mean age of 53 -+ 13.9 years 
(range 36 to 66) and a mean weight of 76 _+ 14.0 kg. Ten were 
in blood group O, three blood group A and one blood group B. 
Preoperative hemodynamic variables were as follows: mean 
systolic blood pressure 89.6 -+ 10.5 mm Hg, mean pulmonary 
artery pressure 32 - 5.2 mm Hg, pulmonary capillary wedge 
pressure 18 _ 4.6 mm Hg, pulmonary vascular esistance 2.5 + 
0.6 Woods units and cardiac index 2.5 _+ 0.6 liters/min per m 2. 
Mean serum creatinine level was 1.9 + 0.8 mg/dl. 
Donors. Donors (10 men, 4 women) had a mean age of 45 _+ 
9.8 years (range 27 to 57) and a mean weight of 75 _+ 14.4 kg. 
The average donor/recipient weight ratio was 0.98 _+ 0.05 
(range 0.91 to 1.08). The average inpatient waiting period of 
the control group for transplantation was 37 + 14.4 days (p = 
0.001 vs. the undersized onor heart group) (Table 1). 
Postoperative outcome. All patients survived and were 
discharged from the heart transplant service after a mean 
length of stay after transplantation f 16.9 _+ 9.4 days for the 
undersized onor heart group and 11.3 _+ 4.9 days for the 
normal control group (p = 0.07). Eleven (79%) of 14 patients 
with undersized onor hearts, and none of the control group, 
required further inpatient rehabilitation (mean length of stay 
in the inpatient rehabilitation unit of our hospital was 16 _+ 9.8 
days) after transplantation. One patient in the undersized 
donor heart group had respiratory failure from cytomegalovi- 
rus pneumonia requiring a 45-day stay in the ventilator step- 
down unit before being weaned from ventilatory support. 
Rejection. The number of rejections between the two 
groups was not significantly different. The recipients of under- 
*p < 0.05, control versus undersized hearts at 5 weeks. ?p < 0.05, control 
versus undersized hearts at 10 weeks. PAP = pulmonary artery pressure; 
PCWP = pulmonary capillary wedge pressure. 
sized hearts had 1.8 + 0.4 episodes of rejection and the control 
group 1.3 + 0.5 in the first 10 weeks after transplantation. 
Hemodynamie variables. The hemodynamic variables for 
both groups were measured at intervals of 5 and 10 weeks by 
right heart catheterization a d are compared in Table 2. There 
was a tendency toward higher pulmonary pressures, higher 
heart rate and lower cardiac indexes for the undersized onor 
heart group, but these findings were not statistically significant. 
By the 10th week after transplantation, the pulmonary pres- 
sures for both groups were declining, as were the heart rates. 
Cardiac indexes also started to improve over the course of the 
study period. 
Echocardiographie findings. Echocardiographic findings in 
the two groups over the 10 weeks are compared in Figures 1 to 3. 
Left ventricular mass increased from 116 _+ 9.1 to 245 + 24 g 
(p = 0.009) in the undersized hearts over the 10 weeks but 
plateaued between 161 +_ 13 and 181 _+ 8 g (p = 0.12) in the 
control group between weeks 5 and 10. Left ventricular mass 
also became greater in the undersized hearts than in the 
control group by the fifth week (196 -+ 36 vs 181 _+ 8 g). 
Therefore, in the undersized hearts there was a statistically 
significant change in left ventricular mass over the 10 weeks 
from that at preimplantation baseline, but no such change was 
noted in the control group (Fig. 1). 
There was a much greater increase in left ventricular 
systolic and diastolic diameters in the undersized hearts (from 
Figure 1. Bar graph comparing rowth in left ventricular mass from 
time of implantation to 10 weeks after transplantation in undersized 
and conventionally sized donor hearts. *p < 0.05 (vs. baseline of 
undersized hearts). 
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Figure 2. Line plots comparing growth in left ventricular diastolic 
(LVd) and systolic (LVs) chamber sizes from time of implantation to 
10 weeks after transplantation in undersized and conventionally sized 
donor hearts. 
3.72 _+ 0.66 to 4.61 _+ 0.49 cm for left ventricular diameter, 
p = 0.04) over 10 weeks than in the control hearts (from 
4.3 _+ 0.85 to 4.36 _+ 0.58 cm for left ventricular diameter, p = 
0.9), which tended to plateau between 5and 10 weeks (Fig. 2). 
Posterior and septal wall thicknesses also increased to a 
greater degree (from 0.91 z 0.3 to 1.08 + 0.15 cm for posterior 
wall thickness, p = 0.2) in the undersized hearts than in the 
control group (from 0.95 _+ 0.24 to 1.09 +_ 0.13 cm, p = 0.3) but 
continued to maintain a relatively constant ratio to left ven- 
tricular internal dimensions (Fig. 3). Comparison between the 
two groups howed no significant differences in left ventricular 
ejection fraction, which ranged from 55% to 65% in both 
groups. 
Discussion 
Congestive heart failure. Heart failure is the only cardio- 
vascular disorder that is increasing in prevalence in the United 
States, with 2.5 to 3 million people (1% of the population) 
afflicted with this disorder. The medical management of con- 
gestive heart failure has evolved significantly over the past 15 
years; however, transplantation remains the only effective 
treatment for end-stage heart disease that cannot be amelio- 
rated by maximal medical management or other surgical 
Figure 3. Line plots comparing growth in posterior (PWT) and septal 
wall thickness (SWT) from time of implantation to 10 weeks after 
transplantation n undersized and conventionally sized donor hearts. 
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intervention. The growing prevalence of congestive heart 
failure has increased the demand for heart ransplantation, but 
the availability of donor hearts has remained stagnant. This 
inequity in the donor pool has contributed significantly to the 
mortality rates of patients with end-stage cardiomyopathy 
awaiting transplantation, with national reports (2) indicating 
that 20% to 50% of patients die while on the transplant waiting 
list. 
Mechanical assist devices as bridges to transplantation may 
stabilize severely impaired patients until a donor organ be- 
comes available and thus may ultimately decrease the mortality 
associated with the end-stage heart (14,15). However, because 
of their current limitations, mechanical ssist devices cannot be 
used as an alternative to orthotopic heart transplantation. I  
addition, these devices are not widely available. Many patients 
also have contraindications that would prohibit the use of 
ventricular assist devices. Left ventricular assist devices there- 
fore cannot, at present expand the donor pool or serve as an 
alternative to heart ransplantation. 
Expanding the donor pool. An alternative approach for 
expanding the donor pool is the use of hearts from older 
donors (>50 years old). This approach as been used by many 
transplant centers around the country. However, a recent 
UNOS study by Breen et al. (16) suggests that when hearts 
from older donors are used, the risk of posttransplant mortality 
is substantially increased such that many patients are better off 
not receiving such hearts. Consequently, expanding the donor 
pool by using older donor hearts may not be desirable. 
Reevaluation of the donor criteria for acceptable organs is 
needed to expand the donor pool. Areas of underutilization 
within the current pool should also be evaluated. 
Undersized donor hearts. Some of the concerns regarding 
utilization of undersized donor hearts include the possibility of 
right ventricular failure due to recipient pulmonary hyperten- 
sion and the inability of the graft to provide adequate circula- 
tion in the larger adult hemodynamic milieu (3,17). Previous 
studies (7-9) have shown that downsizing to a donor/recipient 
weight ratio of 0.65 was well tolerated by orthotopic heart 
transplant recipients and that these smaller hearts demon- 
strated excellent hemodynamic and exercise performance by 
respiratory gas exchange analysis 1 year after transplantation. 
The "restrictive" physiologic function observed at 3 months 
after transplantation in previous tudies (8) normalized over a 
period of 1 year. Animal models of undersized transplanted 
hearts (18) suggest hat hearts can adapt rapidly to altered 
pressure and volume loads and can show marked remodeling 
over time to maintain the circulatory burden. In the pediatric 
population, echocardiographic studies (19-21) have shown 
that the transplanted hearts grow with the recipient. 
The evidence that allografts have the ability to adapt o new 
hemodynamic burdens uggests that expanding the limits of 
the donor/recipient weight ratio to <0.65 may be feasible. We 
hypothesized that the undersized onor hearts could rapidly 
adapt o the new hemodynamic environment and that after the 
immediate posttransplant period, the allografts could maintain 
an appropriate circulation. 
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The donor/recipient ratio has been calculated using the 
body weight, but a study by Chanet al. (22) has shown that the 
echocardiographically derived left ventricular internal dimen- 
sions in normal volunteers (mean left ventricular diastolic 
diameter 5.0 +_ 3.7, mean left ventricular systolic diameter 
3.1 _+ 3.0) do not correlate with weight within a range of 42 to 
118 kg. Therefore, a more accurate comparison may be to use 
the left ventricular internal dimensions as the criteria for the 
match. The limitation of this technique is that these measure- 
ments do not account for left ventricular chamber dilation with 
heart failure that is disproportionate the body size. 
Present study. Our patients had end-stage cardiomyopathy 
and were in the terminal stages of heart failure, requiring 
maximal inotropic support, without much chance of survival 
without immediate transplantation. Mechanical assist devices 
were not an options for 13 of the 14 patients for previously 
stated reasons. The last patient had a Thoratec left ventricular 
assist device and Candida fungemia involving the cannulas, 
necessitating removal of the cannulas and all other foreign 
materials. All 14 patients howed signs of hypoperfusion with 
renal insufficiency and respiratory failure before transplanta- 
tion. 
The operative procedure has been described by Jeevanan- 
dam et al. (11). Triiodothyronine was used before harvesting 
the undersized donor hearts but not the control donor hearts. 
During and after the implantation procedure, intravenous 
prostaglandin Ej was used to decrease pulmonary vascular 
resistance and pressures and to reduce afterload. Cardiac 
output was primarily determined by heart rate because smaller 
hearts have little capacity to vary stroke volume. Isoproterenol 
and synchronized pacing were used to elevate heart rate and 
thus augment ventricular filling and cardiac output (23). 
There were no significant differences in length of stay in the 
cardiac transplant service, but the undersized onor heart 
group (largely because of their extremely debilitated pretrans- 
plant state from end-stage cardiomyopathy) needed to con- 
tinue inpatient rehabilitation after discharge. There were no 
significant differences in the grade or number of rejections in 
either group during the first 10 weeks after transplantation 
(mean episodes of rejection 1.8 + 0.4 for the undersized donor 
heart group and 1.3 _+ 0.5 for the control group). 
Hemodynamic variables. Although pulmonary pressures 
were higher in the undersized donor heart group immediately 
after transplantation, they decreased over time. Because of the 
smaller stroke volume in the undersized onor hearts, heart 
rate exhibited a compensatory increase to maintain an ade- 
quate cardiac index. Elevated filling pressures were most likely 
due to the acute volume and pressure overload imposed on the 
smaller hearts. Filling pressures were reduced as the heart 
remodeled to the new hemodynamic environment. Previous 
investigators (7,9) have shown that there was no correlation 
between hemodynamic variables and donor/recipient weight 
ratio 1 year after transplantation. This finding suggests that 
intrinsic adaptation of the donor heart has already occurred, 
and compensatory hemodynamic changes are therefore no 
longer necessary. This adaptive process correlated with the 
echocardiographically proven growth in the left ventricular 
mass shown in our study. 
Echocardiographic findings. The echocardiographic data 
showed asignificant increase in the left ventricular mass of the 
donor hearts of the undersized donor heart group over the 10 
weeks. Left ventricular diastolic and systolic measurements 
also increased but remained proportional to posterior and 
septal wall thicknesses. By the fifth week after transplantation, 
the left ventricular mass of the undersized hearts had exceeded 
that of the control hearts, suggesting that the former were 
undergoing more extensive adaptive changes mediated by 
pressure and volume factors. The observed increase in wall 
thickness paralleled chamber dilation and thus maintained 
relatively constant wall stress. This growth coincides with 
decreases in pulmonary pressures and increases in cardiac 
indexes. It is likely that both neurohumoral f ctors and intrin- 
sic myocyte responses to the altered pressure and volume load 
contribute to these hemodynamic adaptations. There was no 
correlation between donor age and the amount of increase in 
heart dimensions. Analysis of whether there is a limit to the 
stress-induced increase in heart size in pediatric donor hearts 
may require a longer follow-up period. 
The present study followed a subgroup of moribund pa- 
tients with end-stage cardiomyopathy who were rescued by 
transplantation with undersized allografts. These patients oth- 
erwise would have succumbed toheart failure. Our experience 
indicates that lowering the donor/recipient weight ratio to 
-<0.50 is a valid means of alleviating the critical shortage of 
donor hearts. 
Study limitations. The limitations of the present study 
include 1) the small number of patients tudied prospectively; 
2) the small number of patients followed up retrospectively (3 
of 14); and 3) the short duration of follow-up for these 
patients. The data suggest that undersizing the donor/recipient 
weight ratio to -<0.50 can result in a good outcome. 
Conclusions. We are conducting further studies to assess 
the effects of significant donor/recipient mismatches on long- 
term cardiac allograft function, survival, neurohumoral vari- 
ables, myocardial growth factor gene expression and adapta- 
tion of the undersized heart to the recipient circulatory 
demands. These studies will include long-term follow-up of 
recipients of undersized onor hearts and the control group 
and will assess graft function, hemodynamic variables, episodes 
of rejection, number of hospital admissions and functional 
capacity through oxygen consumption exercise testing. 
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